Inventor · disambiguated record
Carol Routledge
Also filed as: ROUTLEDGE CAROL
3 granted patents·8 pending applications·34 citations·filing 1999–2025
67Inventor score
Top patents by PatentIndex Score
11 records- 0173US6627661B2Use of 5HT-6 antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Sep 30, 2003·10 cites·1 claims
- 0262US6380199B1Use of 5HT6 antagonistsSMITHKLINE BEECHAN P L C·Filed 1999·Granted Apr 30, 2002·24 cites·4 claims
- 0362US2024325351A1Method of administrationCYBIN UK LTD·Filed 2024·Application pending·0 cites
- 0458US12318477B2Injectable and inhalable formulationsCYBIN UK LTD·Filed 2022·Granted Jun 3, 2025·0 cites·21 claims
- 0557US2025032450A1Injectable and inhalable formulationsCYBIN UK LTD·Filed 2022·Application pending·0 cites
- 0655US2009281078A1Combination of sabcomeline with a neuroleptic agent to treat psychotic disordersROUTLEDGE CAROL·Filed 2009·Application pending·0 cites
- 0755US2008081804A1Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic DisordersROUTLEDGE CAROL·Filed 2005·Application pending·0 cites
- 0848US2025262145A1Injectable and inhalable formulationsCYBIN UK LTD·Filed 2025·Application pending·0 cites
- 0947US2008306043A1Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar DisordersROUTLEDGE CAROL·Filed 2005·Application pending·0 cites
- 1045US2007270428A1Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive DisordersHAGAN JAMES·Filed 2004·Application pending·0 cites
- 1136US2007142411A1Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disordersHAGAN JAMES·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carol Routledge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →